We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600143:SSEKingfa Sci. & Tech. Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥17.11

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kingfa Sci. & Tech. is trading at ¥17.11, essentially at its calculated support level of ¥17.11, while the 20‑day SMA (¥18.44) and 50‑day SMA (¥19.19) sit well above the current price, indicating short‑term downside pressure. The RSI of 32.8 suggests the stock is approaching oversold conditions, yet the MACD histogram remains negative and the signal line is bearish, reinforcing a cautious technical outlook. Valuation metrics are stark: a trailing P/E of 36.4 versus a DCF‑derived fair value of ¥7.45 points to a significant premium, and the forward P/E of 22.9 still implies limited upside.
Fundamentally, revenue growth is modest at 5% with thin gross (10.9%) and operating margins (5.0%), while the company carries a heavy debt load (debt‑to‑equity ≈ 132) and generated negative free cash flow, raising concerns about financial resilience. The dividend yield of 0.57% and a modest payout ratio of 21% look sustainable on paper, but the weak cash conversion and high leverage cast doubt on long‑term dividend reliability. Combined with high 30‑day volatility (≈31%) and a low beta, the stock presents a mixed risk profile despite the market’s “Extreme Greed” sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is at technical support with limited upside
  • RSI near oversold but MACD remains bearish
  • Decreasing volume suggests weakening buying interest

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Significant overvaluation relative to DCF fair value
  • High leverage and negative free cash flow
  • Bearish MACD and lack of earnings acceleration

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Sustained debt burden limits strategic flexibility
  • Margins remain thin in a competitive specialty chemicals sector
  • Dividend sustainability is questionable given cash flow constraints

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin1.73%
P/E Ratio36.4
ROE2.67%
ROA1.93%
Debt/Equity131.78
P/B Ratio2.3
Op. Cash FlowCN¥3.7B
Free Cash FlowCN¥-713288896

Technical Analysis

TrendNeutral
RSI32.8
SupportCN¥17.11
ResistanceCN¥19.88
MA 20CN¥18.44
MA 50CN¥19.19
MA 200CN¥16.57
MACDBearish
VolumeDecreasing
Fear & Greed Index80.52

Valuation

Fair ValueCN¥7.45
GradeOvervalued
TypeBlend
Dividend Yield0.57%

Risk Assessment

Beta0.20
Volatility31.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.